These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35439264)

  • 21. Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.
    McLean E; Price A; Chihana M; Kayuni N; Marston M; Koole O; Zaba B; Crampin A;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):391-398. PubMed ID: 28653969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi.
    Kim MH; Zhou A; Mazenga A; Ahmed S; Markham C; Zomba G; Simon K; Kazembe PN; Abrams EJ
    PLoS One; 2016; 11(2):e0149527. PubMed ID: 26901563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.
    van Lettow M; Tweya H; Rosenberg NE; Trapence C; Kayoyo V; Kasende F; Kaunda B; Hosseinipour MC; Eliya M; Cataldo F; Gugsa S; Phiri S;
    Reprod Health; 2017 Jul; 14(1):82. PubMed ID: 28693525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
    Koss CA; Natureeba P; Kwarisiima D; Ogena M; Clark TD; Olwoch P; Cohan D; Okiring J; Charlebois ED; Kamya MR; Havlir DV
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):279-284. PubMed ID: 27828878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
    Wesevich A; Hosseinipour MC; Golin CE; McGrath N; Tsidya M; Chimndozi L; Bhushan N; Hoffman I; Miller WC; Rosenberg NE
    AIDS Care; 2020 Feb; 32(2):170-174. PubMed ID: 31238717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.
    Tabatabai J; Namakhoma I; Tweya H; Phiri S; Schnitzler P; Neuhann F
    Glob Health Action; 2014; 7():24795. PubMed ID: 25280736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VITAL Start: Video-Based Intervention to Inspire Treatment Adherence for Life-Pilot of a Novel Video-Based Approach to HIV Counseling for Pregnant Women Living with HIV.
    Kim MH; Ahmed S; Tembo T; Sabelli R; Flick R; Yu X; Mazenga A; Le Blond H; Simon K; Hartig M; Wetzel E; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Abrams EJ
    AIDS Behav; 2019 Nov; 23(11):3140-3151. PubMed ID: 31410618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
    Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
    Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
    Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
    BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low antiretroviral therapy uptake and low early retention among pregnant women who tested positive for human immunodeficiency virus in informal health centers in urban and semi-rural settings in Cameroon: a prospective cohort study.
    Onambele AAS; Yuya F; Schouame AA; Nolna SK; Socpa A
    Front Public Health; 2023; 11():1188749. PubMed ID: 37601184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
    Tenthani L; Haas AD; Tweya H; Jahn A; van Oosterhout JJ; Chimbwandira F; Chirwa Z; Ng'ambi W; Bakali A; Phiri S; Myer L; Valeri F; Zwahlen M; Wandeler G; Keiser O
    AIDS; 2014 Feb; 28(4):589-598. PubMed ID: 24468999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo.
    Zotova N; Familiar I; Kawende B; Kasindi FL; Ravelomanana N; Parcesepe AM; Adedimeji A; Lancaster KE; Kaba D; Babakazo P; Yotebieng M
    J Int AIDS Soc; 2022 Feb; 25(2):e25865. PubMed ID: 35129301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probable antenatal depression at antiretroviral initiation and postpartum viral suppression and engagement in care.
    Harrington BJ; Pence BW; Maliwichi M; Jumbe AN; Gondwe NA; Wallie SD; Gaynes BN; Maselko J; Miller WC; Hosseinipour MC;
    AIDS; 2018 Nov; 32(18):2827-2833. PubMed ID: 30234603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
    Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
    Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.
    Price AJ; Kayange M; Zaba B; Chimbwandira FM; Jahn A; Chirwa Z; Dasgupta AN; Katundu C; Saul JL; Glynn JR; Koole O; Crampin AC
    Sex Transm Infect; 2014 Jun; 90(4):309-14. PubMed ID: 24714445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.